Concentra Group Holdings Parent, Inc. · NYSE:CON

Concentra Group Holdings Parent — Q3 2025 Earnings Presentation

18 slides from Concentra Group Holdings Parent's earnings presentation, Nov 6, 2025

  1. Slide 1: 3rd Quarter 2025 Results

    3 Quarter 2025 rd Results November 6, 2025 ©2025 Concentra Inc. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express Concentra Group Holdings Parent, Inc.'s ("Concentra," the "Company," "we" or "our") current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events

  3. Slide 3: Concentra At-a-Glance

    Concentra At-a-Glance Concentra is the largest provider of occupational health services in the United States by number of locations1, with a mission of improving the health of America’s workforce, one patient at a time KEY STATISTICS ROBUST FINANCIALS* 628 413 $2.1bn $414mm Occupational health Onsit

  4. Slide 4: We Continue to Deliver on Goals & Key Initiatives

    We Continue to Deliver on Goals & Key Initiatives Operational Strong Q3 performance with +17.0% Revenue growth (+10.6% excluding Nova) and +17.1% Adjusted EBITDA1 growth YoY & Financial (slight uptick in Adjusted EBITDA margin1) Continued robust volume growth excluding Nova, with Workers’ Compensati

  5. Slide 5: Q3 2025 Performance

    Q3 2025 Performance Q3 2025 Q3 2024 YoY (∆) Commentary Facility Count (end of period) Occupational Health Centers 628 549 +79 Due to Nova acquisition (67) and other M&A and de novos Onsite Health Clinics 413 156 +257 Due to Pivot Onsite acquisition (240+) KPIs Visits per Day (“VPD”) 55.6k 50.9k 9.2%

  6. Slide 6: YTD 2025 Performance

    YTD 2025 Performance YTD 2025 YTD 2024 YoY (∆) Commentary Facility Count (end of period) Occupational Health Centers 628 549 +79 Due to Nova acquisition (67) and other M&A and de novos Onsite Health Clinics 413 156 +257 Due to Pivot Onsite acquisition (240+) KPIs Visits per Day (“VPD”) 53.8k 50.1k 7

  7. Slide 7: Balance Sheet & Capital Allocation Strategy

    Balance Sheet & Capital Allocation Strategy Heightened focus on acquisition integration and de-levering for remainder of 2025 Capital Allocation Strategy Net Leverage Liquidity (Net leverage as multiple of Adj. EBITDA1, calculation per credit agreement) ($ in millions) Leverage Prudent management of

  8. Slide 8: Raising 2025 Full-Year Guidance

    Raising 2025 Full-Year Guidance FY 2025 FY 2024 Actual YoY Growth (%) Commentary Guidance Raising previous FY 2025 guidance Total Revenue $1,900.2mm $2.145bn – $2.160bn 13% – 14% ($2.13bn – $2.16bn) Raising previous FY 2025 guidance Adjusted EBITDA1 $376.9mm $425mm – $430mm 13% – 14% ($420mm – $430m

  9. Slide 9: Appendix

    Appendix ©2025 Concentra Inc. All rights reserved.

  10. Slide 10: We Deliver High Quality Service to Employers and Patients Through Multiple Access Points

    We Deliver High Quality Service to Employers and Patients Through Multiple Access Points Occupational Health Onsite Health Centers Clinics Telemed Virtual # of Facilities1 628 413 24/7 Each center serves hundreds of employers Each clinic dedicated to a single Customer Base ~200,000 employers, rangin

  11. Slide 11: We Have a Highly Diverse Business with Strong Underlying Fundamentals

    We Have a Highly Diverse Business with Strong Underlying Fundamentals and Minimal Stroke-of-the-Pen Risk Attractive payor mix1 Broad geographic mix2 Texas Medicare & Other Urgent & Commercial 16% <1% 2% Workers’ Employer Compensation California Employers, insurance Remaining States 16% Services 53%

  12. Slide 12: We Deliver Consistent Revenue and Adjusted EBITDA Growth

    We Deliver Consistent Revenue and Adjusted EBITDA Growth TTM Total Revenue ($bn) TTM Adjusted EBITDA1 ($mm) $414 $2.09 +7.2% CAGR +8.1% CAGR $397 $2.01 $383 $1.93 $377 $1.88 $1.90 $364 $365 $368 $1.81 $1.84 $1.85 $1.86 $355 $361 $1.76 $1.78 $339 $346 $1.72 $334 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

  13. Slide 13: Our Long-Term Financial Targets

    Our Long-Term Financial Targets Stable Revenue Consistent Robust Free Prudent Dividend Growth Profitability with Cash Flow2 Deleveraging Continued Generation Strategy Improvement Mid-to-High 20%+ >80% <3.0x $0.0625 Single-digit growth Adjusted EBITDA Annual FCF Targeted net leverage3 Quarterly cash

  14. Slide 14: Reconciliation of Net Income to Adjusted EBITDA

    Reconciliation of Net Income to Adjusted EBITDA Three Months Ended Sep. 30, Nine Months Ended Sep. 30, TTM Sep. 30, ($ in thousands) 2025 2024 2025 2024 2025 Revenue $572,800 $489,638 $1,624,337 $1,435,151 $2,089,378 Net Income $49,822 $45,759 $136,658 $149,097 $159,458 Income Tax Expense 15,967 16,

  15. Slide 15: Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance

    Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance Range ($ in millions) Low High Net Income Attributable to the Company $156 $161 Net Income Attributable to Non-Controlling Interests 7 7 Net Income $163 $168 Loss on Early Retirement of Debt 1 1 Income Tax Expense 53 55 Interest Expense 110 1

  16. Slide 16: Reconciliation to TTM Adjusted EBITDA since Q4 2022

    Reconciliation to TTM Adjusted EBITDA since Q4 2022 TTM ($ in thousands) Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Income from Operations $258,529 $263,667 $272,434 $281,673 $287,632 Depreciation and Amortization 73,667 73,165 72,718 72,896 73,051 Stock Compensation Expense 2,141 1,784 1,248 713 651 S

  17. Slide 17: Reconciliation to Free Cash Flow

    Reconciliation to Free Cash Flow ($ in millions) TTM Sep. 30, 2025 Net Cash Provided by Operating Activities $254 Net Cash Used in Investing Activities $(411) Business Combinations, Net of Cash Acquired $333 Free Cash Flow $176 ©2025 Concentra Inc. Note: May not foot due to rounding All rights reser

  18. Slide 18: Improving the health of America's workforce, one patient at a time.

    Improving the health of America’s workforce, one patient at a time.

Concentra Group Holdings Parent — Q3 2025 Earnings Presentation on 6ix